Celldex Therapeutics Inc. (CLDX)
NASDAQ: CLDX
· Real-Time Price · USD
21.37
1.84 (9.42%)
At close: Jun 06, 2025, 3:59 PM
21.35
-0.09%
After-hours: Jun 06, 2025, 04:59 PM EDT
9.42% (1D)
| Bid | 19.51 |
| Market Cap | 1.42B |
| Revenue (ttm) | 7.56M |
| Net Income (ttm) | -178.85M |
| EPS (ttm) | -2.7 |
| PE Ratio (ttm) | -7.91 |
| Forward PE | -4.93 |
| Analyst | Buy |
| Ask | 22.05 |
| Volume | 708,191 |
| Avg. Volume (20D) | 869,841 |
| Open | 19.87 |
| Previous Close | 19.53 |
| Day's Range | 19.87 - 21.43 |
| 52-Week Range | 14.40 - 47.00 |
| Beta | 1.14 |
About CLDX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLDX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CLDX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts8 months ago
-12.06%
Celldex Therapeutics shares are trading lower. The...
Unlock content with
Pro Subscription
10 months ago
-8.45%
Celldex Therapeutics shares are trading lower. The company announced topline results from its Phase 2 clinical trial of barzolvolimab.
